Reports
Sale
Global Head and Neck Cancer Therapeutics Market Size, Report: By Therapy Type: Chemotherapy, Immunotherapy, Targeted Therapy, Radiation Therapy; By Route of Administration: Oral, Parenteral; By Distribution Channel: Hospital Pharmacies, Drug Stores & Retail Pharmacies; Regional Analysis; Supplier Landscape; 2024-2032
Global Head and Neck Cancer Therapeutics Market Outlook
The global head and neck cancer therapeutics market size reached a value of USD 1.67 billion in 2023, driven by the rising prevalence of cancer. The market is expected to grow at a CAGR of 11.2% during the forecast period of 2024-2032, likely to attain a value of around USD 4.32 billion by 2032.
Head and Neck Cancer Therapeutics: Introduction
Head and neck cancer can be inclusive of different cancers, including throat cancer, voice box cancer, and mouth cancer, among others. These squamous cell cancers usually form up in the salivary glands or sinuses. Head and neck cancer can be treated if they are diagnosed timely. Different approaches are taken to treat these cancers, depending on the symptoms and severity of the condition. The therapeutic process has to be decided carefully, with the primary goal of removing the tumour. It should also be ensured that the functioning of the nearby nerves, organs, and tissues is not hampered by the treatment process.
The therapeutic options for head and neck cancer can be categorised into chemotherapy, radiation therapy, immunotherapy, targeted therapy, and surgery, depending on what would suit the patient and work more efficiently for them.
Key Trends in the Head and Neck Cancer Therapeutics Market
The growth of the market is primarily driven by the rising demand for treatment with the rapidly rising prevalence of cancers across the globe. The growing demand for innovative and effective therapies has been aiding the development of the market. The rising prevalence of cancer can be majorly attributed to the rising consumption of tobacco-based products like cigarettes, and the rising prevalence of alcoholism. The emergence of new and advanced technology is also anticipated to bolster the demand for the therapeutics.
Global Head and Neck Cancer Therapeutics Market Analysis
Based on type, the market is divided into therapy type, route of administration, distribution channel, and region.
Market Breakup by Therapy Type
- Chemotherapy
- Immunotherapy
- Targeted Therapy
- Radiation Therapy
Market Breakup by Route of Administration
- Oral
- Parenteral
Market Breakup by Distribution Channel
- Hospital Pharmacies
- Drug Stores and Retail Pharmacies
- Online Pharmacies
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Head and Neck Cancer Therapeutics Market Scenario
The growth of the head and neck cancer therapeutics market is driven by a variety of factors. Based on regions, North America has been dominating the global market and it is likely that the region will continue its dominance over the coming years as well. The rapid development of the healthcare sector, along with the rising support from the government and technological advancement, is anticipated to propel significant impetus to the growth of the market.
Head and Neck Cancer Therapeutics Market: Competitive Landscape
The comprehensive EMR report provides an in-depth assessment of the market based on Porter's five forces model, along with giving a SWOT analysis. The report gives a detailed analysis of the following key players in the global head and neck cancer therapeutics market, covering their competitive landscape and the latest developments like mergers, acquisitions, investments, and expansion plans.
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players.
- AstraZeneca Plc.
- Bristol-Myers Squibb Company
- Eli Lilly and Company
- F. Hoffmann-La Roche Ltd. (Genentech, Inc.)
- Fresenius Medical Care AG & Co. KGaA
- Merck & Co., Inc.
- Pfizer Inc.
- Sanofi
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Limited
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Therapy Type |
|
| Breakup by Route of Administration |
|
| Breakup by Distribution Channel |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Head and Neck Cancer Overview
3.1 Guidelines and Stages
3.2 Pathophysiology
3.3 Screening and Diagnosis
3.4 Treatment Pathway
4 Patient Profile
4.1 Patient Profile Overview
4.2 Patient Psychology and Emotional Impact Factors
4.3 Risk Assessment and Treatment Success Rate
5 Head and Neck Cancer Epidemiology Analysis
5.1 Epidemiology Overview (2016-2031)
5.2 North America Head and Neck Cancer Epidemiology (2016-2031)
5.3 Europe Head and Neck Cancer Epidemiology (2016-2031)
5.4 Asia-Pacific Head and Neck Cancer Epidemiology (2016-2031)
5.5 Latin America Head and Neck Cancer Epidemiology (2016-2031)
5.6 Middle East & Africa Head and Neck Cancer Epidemiology (2016-2031)
6 Global Head and Neck Cancer Therapeutics Market Overview
6.1 Global Head and Neck Cancer Therapeutics Market Historical Value (2017-2023)
6.2 Global Head and Neck Cancer Therapeutics Market Forecast Value (2024-2032)
7 Global Head and Neck Cancer Therapeutics Market Landscape
7.1 Head and Neck Cancer Therapeutics: Developers Landscape
7.1.1 Analysis by Year of Establishment
7.1.2 Analysis by Company Size
7.1.3 Analysis by Region
7.2 Head and Neck Cancer Therapeutics: Product Landscape
7.2.1 Analysis by Therapy Type
7.2.2 Analysis by Route of Administration
8 Head and Neck Cancer Therapeutics Challenges and Unmet Needs
8.1 Treatment Pathway Challenges
8.2 Compliance and Drop-Out Analysis
8.3 Awareness and Prevention Gaps
9 Cost of Treatment
10 Global Head and Neck Cancer Therapeutics Market Dynamics
10.1 Market Drivers and Constraints
10.2 SWOT Analysis
10.3 Porter’s Five Forces Model
10.4 Key Demand Indicators
10.5 Key Price Indicators
10.6 Industry Events, Initiatives, and Trends
10.7 Value Chain Analysis
11 Global Head and Neck Cancer Therapeutics Market Segmentation
11.1 Global Head and Neck Cancer Therapeutics Market by Therapy Type
11.1.1 Market Overview
11.1.2 Chemotherapy
11.1.3 Immunotherapy
11.1.4 Targeted Therapy
11.1.5 Radiation Therapy
11.2 Global Head and Neck Cancer Therapeutics Market by Route of Administration
11.2.1 Market Overview
11.2.2 Oral
11.2.3 Parenteral
11.3 Global Head and Neck Cancer Therapeutics Market by Distribution Channel
11.3.1 Market Overview
11.3.2 Hospital Pharmacies
11.3.3 Drug Stores & Retail Pharmacies
11.3.4 Online Pharmacies
11.4 Global Head and Neck Cancer Therapeutics Market by Region
11.4.1 Market Overview
11.4.2 North America
11.4.3 Europe
11.4.4 Asia Pacific
11.4.5 Latin America
11.4.6 Middle East and Africa
12 North America Head and Neck Cancer Therapeutics Market
12.1 Market Share by Country
12.2 United States of America
12.3 Canada
13 Europe Head and Neck Cancer Therapeutics Market
13.1 Market Share by Country
13.2 United Kingdom
13.3 Germany
13.4 France
13.5 Italy
13.6 Others
14 Asia Pacific Head and Neck Cancer Therapeutics Market
14.1 Market Share by Country
14.2 China
14.3 Japan
14.4 India
14.5 ASEAN
14.6 Australia
14.7 Others
15 Latin America Head and Neck Cancer Therapeutics Market
15.1 Market Share by Country
15.2 Brazil
15.3 Argentina
15.4 Mexico
15.5 Others
16 Middle East and Africa Head and Neck Cancer Therapeutics Market
16.1 Market Share by Country
16.2 Saudi Arabia
16.3 United Arab Emirates
16.4 Nigeria
16.5 South Africa
16.6 Others
17 Regulatory Framework
17.1 Regulatory Overview
17.1.1 US FDA
17.1.2 EU EMA
17.1.3 INDIA CDSCO
17.1.4 JAPAN PMDA
17.1.5 Others
18 Patent Analysis
18.1 Analysis by Type of Patent
18.2 Analysis by Publication year
18.3 Analysis by Issuing Authority
18.4 Analysis by Patent Age
18.5 Analysis by CPC Analysis
18.6 Analysis by Patent Valuation
18.7 Analysis by Key Players
19 Grants Analysis
19.1 Analysis by year
19.2 Analysis by Amount Awarded
19.3 Analysis by Issuing Authority
19.4 Analysis by Grant Application
19.5 Analysis by Funding Institute
19.6 Analysis by NIH Departments
19.7 Analysis by Recipient Organization
20 Clinical Trials Analysis
20.1 Analysis by Trial Registration Year
20.2 Analysis by Trial Status
20.3 Analysis by Trial Phase
20.4 Analysis by Therapeutic Area
20.5 Analysis by Geography
21 Funding and Investment Analysis
21.1 Analysis by Funding Instances
21.2 Analysis by Type of Funding
21.3 Analysis by Funding Amount
21.4 Analysis by Leading Players
21.5 Analysis by Leading Investors
21.6 Analysis by Geography
22 Partnership and Collaborations Analysis
22.1 Analysis by Partnership Instances
22.2 Analysis by Type of Partnership
22.3 Analysis by Leading Players
22.4 Analysis by Geography
23 Supplier Landscape
23.1 AstraZeneca Plc.
23.1.1 Financial Analysis
23.1.2 Product Portfolio
23.1.3 Demographic Reach and Achievements
23.1.4 Mergers and Acquisitions
23.1.5 Certifications
23.2 Bristol-Myers Squibb Company
23.2.1 Financial Analysis
23.2.2 Product Portfolio
23.2.3 Demographic Reach and Achievements
23.2.4 Mergers and Acquisitions
23.2.5 Certifications
23.3 Eli Lilly and Company
23.3.1 Financial Analysis
23.3.2 Product Portfolio
23.3.3 Demographic Reach and Achievements
23.3.4 Mergers and Acquisitions
23.3.5 Certifications
23.4 F. Hoffmann-La Roche Ltd. (Genentech, Inc.)
23.4.1 Financial Analysis
23.4.2 Product Portfolio
23.4.3 Demographic Reach and Achievements
23.4.4 Mergers and Acquisitions
23.4.5 Certifications
23.5 Fresenius Medical Care AG & Co. KGaA,
23.5.1 Financial Analysis
23.5.2 Product Portfolio
23.5.3 Demographic Reach and Achievements
23.5.4 Mergers and Acquisitions
23.5.5 Certifications
23.6 Merck & Co., Inc.
23.6.1 Financial Analysis
23.6.2 Product Portfolio
23.6.3 Demographic Reach and Achievements
23.6.4 Mergers and Acquisitions
23.6.5 Certifications
23.7 Pfizer Inc.
23.7.1 Financial Analysis
23.7.2 Product Portfolio
23.7.3 Demographic Reach and Achievements
23.7.4 Mergers and Acquisitions
23.7.5 Certifications
23.8 Sanofi
23.8.1 Financial Analysis
23.8.2 Product Portfolio
23.8.3 Demographic Reach and Achievements
23.8.4 Mergers and Acquisitions
23.8.5 Certifications
23.9 Sun Pharmaceutical Industries Ltd.
23.9.1 Financial Analysis
23.9.2 Product Portfolio
23.9.3 Demographic Reach and Achievements
23.9.4 Mergers and Acquisitions
23.9.5 Certifications
23.10 Teva Pharmaceutical Industries Limited
23.10.1 Financial Analysis
23.10.2 Product Portfolio
23.10.3 Demographic Reach and Achievements
23.10.4 Mergers and Acquisitions
23.10.5 Certifications
24 Head and Neck Cancer Therapeutics - Distribution Model (Additional Insight)
24.1 Overview
24.2 Potential Distributors
24.3 Key Parameters for Distribution Partner Assessment
25 Key Opinion Leaders (KOL) Insights (Additional Insight)
26 Company Competitiveness Analysis (Additional Insight)
26.1 Very Small Companies
26.2 Small Companies
26.3 Mid-Sized Companies
26.4 Large Companies
26.5 Very Large Companies
27 Payment Methods (Additional Insight)
27.1 Government Funded
27.2 Private Insurance
27.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The market attained a value of USD 1.67 billion in 2023, driven by the rising cases of neurovascular diseases across the globe.
The market is anticipated to grow at a CAGR of 11.2% during the forecast period of 2024-2032 to attain a value of around USD 4.32 billion by 2032.
The growth of the market is driven by factors like rising awareness about the disease, the increasing availability of the treatment, and the rapid technological advancements.
The key trends which are bolstering the market growth include the rising investment and fundings by government and healthcare organizations.
The major regional markets include North America, Europe, Asia Pacific, Latin America, Middle East and Africa.
The therapy types in the market include chemotherapy, immunotherapy, targeted therapy, and radiation therapy.
The routes of administration include oral and parenteral routes.
The key players in the market can be categorised into AstraZeneca Plc., Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche Ltd. (Genentech, Inc.), Fresenius Medical Care AG & Co. KGaA, Merck & Co., Inc., Pfizer Inc., Sanofi, Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Limited.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER